Cancer Biomarkers


Malignant growth biomarkers also known as cancer biomarkers (CB) are bimolecular created either by the tumor cells or by different cells of the body in light of the tumor, and CB could be utilized as screening/early location instrument of disease, demonstrative, prognostic, or indicator for the general result of a patient. Besides, malignancy biomarkers may distinguish subpopulations of patients who are well on the way to react to a given treatment. Biomarkers can be qualities, quality items, explicit cells, particles, catalysts, or chemicals which can be identified in blood, pee, tissues, or other body liquid.



 


  • Cell Lung Cancer Adhesion Molecules
  • Genetic Mutations
  • Gene Silencing
  • Chromosomal Changes
  • Genomic Instability

Related Conference of Cancer Biomarkers

July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
August 18-19, 2025

6th Cancer Diagnostics & Treatment Conference

Rome, Italy
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
October 22-23, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
October 24-25, 2025

25th World Congress on Cancer and Diagnostics

Zurich, Switzerland
November 20-21, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain
March 23-24, 2026

16th World Congress on Breast Cancer Research & Therapies

Aix-en-Provence, France

Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in